Sienna Resources

LATEST MEDICINAL CANNABIS STOCK NEWS


Innocan Pharma Reports First Quarter 2024 Results with Revenue Growth of over 4X to $6.8 Million

Last Trade: 0.23 0.00 0.00

HERZLIYA, Israel and CALGARY, AB, May 27, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, is pleased to announce its consolidated financial results for the three-month period ended March 31, 2024. First Quarter 2024 Financial... Read more


FDA Has Granted Innocan Pharma a Meeting Date for LPT-CBD for Chronic Pain

Last Trade: 0.23 0.00 0.00

The regulatory approval process with the U.S. Food and Drug Administration has commenced for Innocan's LPT-CBD release technology, marking a key step in the advancement of non-opioid pain management HERZLIYA, Israel and CALGARY, AB, May 21, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), is pleased to announce significant advancements in the... Read more


MediPharm Labs Reports First Quarter Results

Last Trade: 0.06 0.0033 5.53

Completes Major Steps Towards Profitability with Best Revenue and Adjusted EBITDA in Over Three Years TORONTO, May 15, 2024 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids announced its financial results for the three months ended March 31, 2024. Select Highlights... Read more


CV Sciences Reports First Quarter 2024 Financial Results

Last Trade: 0.05 0.0015 2.94

SAN DIEGO, May 14, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended March 31, 2024. First Quarter 2024 and Recent Financial and Operating Highlights Generated... Read more


CV Sciences Acquires Elevated Softgels, A Flexible, Low-Moq, Nutraceutical Manufacturer

Last Trade: 0.05 0.0015 2.94

SAN DIEGO, May 13, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced that it has consummated its purchase of Elevated Softgels, LLC ("Elevated Softgels"), a leading manufacturer of encapsulated... Read more


Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa

Last Trade: 0.19 0.0059 3.16

The study conducted at The Hospital for Sick Children evaluated wound healing, pain, and itch. 55% of patients enrolled in Study reported improvements in wound healing, 45% displayed wound stability. TORONTO, May 13, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization... Read more


Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey

Last Trade: 0.23 0.00 0.00

HERZLIYA, Israel and ALGARY, AB , May 9, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce the successful pre-clinical treatment with a liposomal-CBD injection in a female donkey. Innocan's innovative therapy provided immediate noticeable pain relief and improved... Read more


Leafly Holdings Reports First Quarter 2024 Financial Results

Last Trade: 1.76 0.09 5.39

Delivered Q1 2024 revenue of $9.0 million Reported net loss of $2.4 million and adjusted EBITDA1 loss of $0.9 million Hires financial advisors, PGP and Benchmark, to explore financing and strategic opportunities SEATTLE / May 09, 2024 / Business Wire / Leafly Holdings, Inc. (“Leafly” or “the Company”) (NASDAQ: LFLY), a leading online cannabis discovery marketplace and resource for cannabis consumers, today... Read more


Aurora Cannabis Marks First Shipment of Medical Cannabis to the New Zealand Market

Last Trade: 6.66 0.21 3.26

Canada's Leading Medical Cannabis Company Launches Premium Products Redefining Patient Care EDMONTON, AB, May 8, 2024 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) the Canadian based leading global medical cannabis company, is proud to announce the arrival of Aurora branded medical cannabis products to the New Zealand market. This new line of premium dried flowers represents a... Read more


Entourage Health Reports Fiscal Year 2023 Financial Results and Posts $54 Million in Total Revenues

Last Trade: 0.0092 0.00 0.00

Gross profit before fair value changes reached $2.4 million, reflecting a 126% year-over-year increase. Company demonstrates financial gains with a 23% reduction in the cost of goods sold. SG&A declined 14% compared to the previous year. Color Cannabis secures a #6 spot in the national pre-roll market. TORONTO, April 30, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:... Read more


BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results

Last Trade: 0.18 -0.0038 -2.11

FY 2023 Revenue Increased 2.3x to $12.7 Million USD The Company expects Q1 2024 Revenue to be in the range of $5.2 million to $5.3 million and is providing Q2 2024 Revenue Guidance of $5.7-$6.0 million Management pursuing Nasdaq listing by end of year. General and Special meeting called to approve share consolidation and additional independent director to comply with Nasdaq listing requirements Vancouver,... Read more


Cansortium Reports Fourth Quarter and Full Year 2023 Results

Last Trade: 0.17 0.001 0.61

Q4 Revenue up 9% YoY to a Record $25.5 Million 9th Consecutive Quarter of Positive Cash Flow from Operations TAMPA, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- Cansortium Inc. (CSE: TIUM.U) (OTCQB: CNTMF) (“Cansortium” or the “Company”), a vertically-integrated, multi-state cannabis company operating under the FLUENT™ brand, today announced financial and operating results for the fourth quarter and full year... Read more


Akanda Appoints Cooper to the Board of Directors

Last Trade: 4.11 1.72 71.97

London, United Kingdom--(Newsfile Corp. - April 25, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, Akanda Corp. announces the appointment of Christopher Cooper to its board of directors following the resignation of Harvinder Singh as a director. Mr. Christopher Cooper has over 20 years of extensive business experience in all facets of corporate... Read more


Trulieve Cannabis to Open Medical Cannabis Dispensary in North Palm Beach, Florida

Last Trade: 10.45 -0.04 -0.38

New location on U.S. Highway 1 will host grand opening celebration Friday TALLAHASSEE, Fla., April 22, 2024 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in North Palm Beach, Florida. A grand opening celebration will be held Friday,... Read more


Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain

Last Trade: 0.23 0.00 0.00

With its submission of a Pre-IND Meeting Request Letter, Innocan initiates the regulatory process with the U.S. Food and Drug Administration (FDA) for the approval of its prolonged CBD release technology for human use HERZLIYA, Israel and CALGARY, AB, April 22, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), is pleased to announce that is has reached... Read more


Akanda Announces Plans to Enter Blockchain and AI Technology Sector

Last Trade: 4.11 1.72 71.97

London, United Kingdom--(Newsfile Corp. - April 12, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, announces its plans to enter the blockchain and artificial intelligence sector of the cannabis industry. With an increasingly complex and global supply chain for the international cannabis industry, the Company believes companies and consumers will turn to... Read more


Akanda Announces Closing of the Sale of RPK

Last Trade: 4.11 1.72 71.97

London, United Kingdom--(Newsfile Corp. - April 11, 2024) - On April 1, 2024, Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, completed the transaction with SOMAÍ Pharmaceuticals Ltd. (the "Buyer") for the sale of RPK, its indirect wholly-owned Portuguese subsidiary. Pursuant to the provisions set forth in the definitive share purchase agreement, the cash... Read more


SciSparc to Acquire AutoMax

Last Trade: 1.13 -0.03 -2.59

TEL AVIV, Israel, April 11, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that it signed a merger agreement (the “Agreement”) with AutoMax Motors Ltd. (“AutoMax”), a leading vehicle importer company in... Read more


Flora Growth and IM Cannabis to Bring Vessel Products to the Israeli Market

Last Trade: 1.30 0.10 8.41

Fort Lauderdale, Florida--(Newsfile Corp. - April 10, 2024) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world, has entered into a strategic distribution agreement with IM Cannabis Corp. ("IMC") for Vessel products in Israel. Vessel is a wholly... Read more


Cansortium: Florida's Premier Medical Marijuana Provider FLUENT™ Expands with New Dispensary in Daytona Beach

Last Trade: 0.17 0.001 0.61

TAMPA, Fla., April 05, 2024 (GLOBE NEWSWIRE) -- Cansortium Inc. (CSE: TIUM.U) (OTCQB: CNTMF) (“Cansortium” or the “Company”), a vertically-integrated, multi-state cannabis company operating under the FLUENT™ brand, today announced the opening of its first location in Daytona Beach, marking the company’s 35th dispensary in Florida. Patients with a valid medical marijuana card and ID can now explore FLUENT's... Read more


1933 Industries Reports Q2 2024 Financials

Last Trade: 0.0091 -0.0029 -24.17

VANCOUVER, BC / ACCESSWIRE / April 2, 2024 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its unaudited interim consolidated financial statements for the three and six months ended January 31, 2024 and 2023 ("Q2 2024"). All amounts expressed are in Canadian dollars. The Company owns 91% of Alternative... Read more


Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M

Last Trade: 0.23 0.00 0.00

HERZLIYA, Israel and CALGARY, Alberta, April 1, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies is pleased to announce its audited financial consolidated results for the year ended December 31, 2023. Full Year 2023 Financial... Read more


CV Sciences Reports Fiscal Year-End 2023 Financial Results

Last Trade: 0.05 0.0015 2.94

SAN DIEGO, March 28, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the year and quarter ended December 31, 2023. Fiscal 2023, Fourth Quarter 2023 and Recent Financial and Operating... Read more


Leafly Holdings Reports Fourth Quarter and Full Year 2023 Financial Results

Last Trade: 1.76 0.09 5.39

Delivered Q4 2023 revenue of $9.7 million Reported Q4 2023 net loss of $0.5 million and adjusted EBITDA1 of $1.2 million Focus on operational discipline in 2023 resulted in full year $25 million cost savings over 2022 SEATTLE / Mar 28, 2024 / Business Wire / Leafly Holdings, Inc. (“Leafly” or “the Company”) (NASDAQ: LFLY), a leading online cannabis discovery marketplace and resource for cannabis consumers,... Read more


SciSparc and Clearmind Medicine Collaboration Evolves with New International Patent Application for Preventing and Treating Depression

Last Trade: 1.13 -0.03 -2.59

TEL AVIV, Israel, March 27, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that as part of its ongoing collaboration with Clearmind Medicine Inc. (“Clearmind”) (Nasdaq: CMND) (CSE: CMND) (FSE: CWY), a... Read more


MediPharm Labs Reports Fourth Quarter and Full Year Results

Last Trade: 0.06 0.0033 5.53

Annual Revenue and Adjusted EBITDA Improve by 50% TORONTO, March 27, 2024 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, today announced its financial results for the full year and three months ended December 31, 2023. Select Highlights 2023 full year revenue increased... Read more


CV Sciences Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews

Last Trade: 0.05 0.0015 2.94

Pet Hip and Joint Health Chews and Pet Calming Care Chews improve the physical and emotional well-being of dogs SAN DIEGO, March 26, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, proudly announces its latest... Read more


PharmaCielo to Supply Ease Labs with Commercial Shipments of API to Fulfill Contract with State Government of Sao Paulo, Brazil

Last Trade: 0.13 0.00 0.00

The contract to supply the State of São Paulo is the largest public sector contract awarded to date in Brazil - the State of São Paulo is the largest state in the country. Ease Labs to supply up to 1.871 tons of pharma-grade CBD to the government over a 12-month period. Ease Labs' product is based on PharmaCielo's proprietary API. Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - March 26, 2024) -... Read more


Trulieve Cannabis to Open Medical Cannabis Dispensary in Cocoa Beach, Florida

Last Trade: 10.45 -0.04 -0.38

New Brevard County location will host grand opening celebration Friday, April 5th TALLAHASSEE, Fla., March 26, 2024 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Cocoa Beach, Florida. A grand opening celebration will be held Friday,... Read more


Body and Mind Announces Q2 2024 Financial Results

Last Trade: 0.05 -0.0085 -13.60

Las Vegas, Nevada and Vancouver, British Columbia--(Newsfile Corp. - March 26, 2024) - Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) (the "Company" or "BaM"), a multi-state operations-focused cannabis company, is pleased to announce its financial results for the second quarter of fiscal year 2024 ended January 31, 2024 and to provide shareholders with an operational update. All financial information is provided in... Read more


Innocan Pharma paves its way to LPT-CBD Chemistry, Manufacturing and Controls (CMC), key milestones for FDA approval.

Last Trade: 0.23 0.00 0.00

HERZLIYA, Israel and CALGARY, AB, March 25, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the development of drug delivery technologies using CBD for the pharmaceutical and biotechnology industries, is pleased to announce the signing of an agreement with the Hebrew University, which facilitate  Innocan to initiate the Food and Drug... Read more


SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research

Last Trade: 1.13 -0.03 -2.59

MitoCareX Bio dedicates efforts to creating a predictive AI model to predict small molecules more efficiently TEL AVIV, Israel, March 21, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced that MitoCareX Bio Ltd. ("MitoCareX"), the... Read more


SciSparc Granted Another Patent, Strengthening its Core Technology in Canada

Last Trade: 1.13 -0.03 -2.59

TEL AVIV, Israel, March 18, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, today announced that it has been granted a patent for its core-technology, the combination of cannabinoids and n-acylethanolamines, by the Canadian... Read more


Tilray Medical Receives Approval for First Medical Cannabis Extract in Portugal

Last Trade: 1.85 0.02 1.09

CANTANHEDE, Portugal, March 14, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced a groundbreaking achievement in the medical cannabis industry in Portugal. Following the successful approval of our Tilray whole... Read more


SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial

Last Trade: 1.13 -0.03 -2.59

First patient has been dosed in the randomized, controlled, double blind clinical trial for Autism Spectrum Disorder in pediatric patients TEL AVIV, Israel, March 14, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, today... Read more


SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure

Last Trade: 1.13 -0.03 -2.59

MitoCareX Bio dedicates efforts to creating a predictive AI model to predict small molecules more efficiently TEL AVIV, Israel, March 12, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced that MitoCareX Bio Ltd. ("MitoCareX... Read more


SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder

Last Trade: 1.13 -0.03 -2.59

TEL AVIV, Israel, March 08, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced that the first patient has been enrolled in the Company's clinical trial assessing the efficacy and safety of SCI-210 for the treatment of children with... Read more


SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe

Last Trade: 1.13 -0.03 -2.59

The Company's most recent patent further solidifies its position, complementing existing grants in the U.S., Japan, Australia and other key jurisdictions TEL AVIV, Israel, March 07, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous... Read more


Trulieve Cannabis to Open Express Medical Cannabis Dispensary in Palm Bay, Florida

Last Trade: 10.45 -0.04 -0.38

New location is the Company's second dispensary dedicated to express pickup orders TALLAHASSEE, Fla., March 6, 2024 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new express medical cannabis dispensary in Palm Bay, Florida. A grand opening celebration will be held... Read more


SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology

Last Trade: 1.13 -0.03 -2.59

TEL AVIV, Israel, March 06, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today its had been received patent approval for its proprietary combination of opioids and n-acylethanolamines for pain treatment (the... Read more

COPYRIGHT ©2022 GREEN STOCK NEWS